Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-hormone Closed-loop vs Sensor-augmented Pump in T1D
NCT02488616Phase 2Withdrawn
- Sponsor
- Montreal Clinical Research Institute
- Start
- Mar 2018
- Primary completion
- Nov 2018
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by Montreal Clinical Research Institute. Primary endpoint: Percentage of time of glucose levels spent between 3.9 and 10.0 mmol/L at 120 hours. Planned start Mar 2018; status: withdrawn.
Beyond the preview
Go deeper on NCT02488616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02488616.